| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
620 |
599 |
$58K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
863 |
841 |
$48K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
586 |
582 |
$25K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
842 |
827 |
$12K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,191 |
1,189 |
$11K |
| 96127 |
|
605 |
570 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
107 |
106 |
$5K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
55 |
55 |
$4K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
43 |
43 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
93 |
92 |
$2K |
| 99173 |
|
85 |
85 |
$2K |
| 90461 |
|
44 |
44 |
$2K |
| 94760 |
|
648 |
633 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
61 |
61 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
43 |
43 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$1K |
| 99188 |
|
16 |
16 |
$416.00 |
| 99051 |
|
12 |
12 |
$198.72 |
| 96160 |
|
14 |
14 |
$54.04 |